Amicus Therapeutics, Inc. (FOLD) Posts Q3 Loss of $0.34/Sh
Tweet Send to a Friend
Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q3 EPS of ($0.34), in-line with the analyst estimate of ($0.34). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
